Anybody care to decode this briefing?
RNAi (ribonucleic acid interference) ?
ability to eliminate disease causing proteins from cells ?
lipid nanoparticle (LNP) delivery technology ?
Fast Tract designation from the US FDA for the development of TKM-Ebola
TKM-Ebola, an anti-Ebola viral therapeutic, is being developed under a contract with the U.S. Department of Defense’s (DoD) Joint Project Manager Medical Countermeasure Systems (JPM-MCS).
EBOLA VIRUS: Vaccine stock jumps 50% in one week